STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml
Product details
Registration number: SIN10039P
Classification: Prescription Only
Active ingredients: IPRATROPIUM BROMIDE
Strength: 250 mcg/ml
Dosage form: SOLUTION
Route: RESPIRATORY (INHALATION)
Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
ATC code: R03BB01
HSA approval date: 17 September 1998
Manufacturer(s): IVAX PHARMACEUTICALS UK
Manufacturing country/countries: UNITED KINGDOM
What are the HSA registration number and classification for STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN10039P
Classification: Prescription Only
What active ingredients and strength are recorded for STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: IPRATROPIUM BROMIDE
Strength: 250 mcg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: SOLUTION
Route: RESPIRATORY (INHALATION)
Who is the recorded registrant for STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml?
According to the HSA dataset updated 7 August 2026:
Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): IVAX PHARMACEUTICALS UK
Manufacturing country/countries: UNITED KINGDOM
Where can I look up STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN10039P or the exact product name STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml. The general register link does not preselect this product.
What are the source dates for this STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN10039P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)